Assessment of microvascular function after reperfused acute myocardial infarction (AMI) provides important insights for myocardial reperfusion and facilitates prediction of long-term left ventricular (LV) function and clinical outcome. In this study, we examined microvascular integrity 48 h after successful primary percutaneous coronary intervention (PCI) and compared predictive accuracy of the intracoronary pressure-wire-and transthoracic Doppler echocardiography-based parameters in the estimation of long-term LV infarct size and function.
The study group consisted of 30 anterior AMI patients who were treated successfully with primary PCI. Two days after primary PCI, microvascular integrity was evaluated. Coronary flow reserve (CFR), collateral flow index (CFIp), coronary wedge pressure (CWP), and index of microvascular resistance (IMR) were determined using intracoronary pressure wire. Deceleration time of coronary diastolic flow (DDT) was measured using transthoracic echocardiography. At 6 months, coronary angiography, echocardiography, and infarct size measurement were performed. Area under the curve, sensitivity, and specificity of the indices of microvascular perfusion in the prediction of lateterm infarct size were as follows: IMR (0.68 + 0.15, 69%, 60%), CFR (0.67 + 0.10, 66%, 59%), CWP (0.69 + 0.12, 70%, 72%), CFIp (0.64 + 0.10, 65%, 78%), and DDT (0.68 + 0.16, 69%, 79%). All of the microvascular perfusion indices, which have been used in this study, had comparable sensitivity and specificity in the prediction of longterm ejection fraction. There were no significant differences between areas under the curve of microvascular perfusion indices in the prediction of long-term infarct size and ejection fraction.
Conclusion
As a non-invasive parameter, DDT was found to be as accurate as the invasive parameters of microvascular function in estimating long-term infarct size and LV function. Thus, simply measuring DDT in the reperfused infarct-related artery might provide useful and reliable estimate for early risk stratification.
It has been known that there is a link between early-phase microvascular dysfunction and long-term infarct size, left ventricular (LV) geometry, and performance after acute myocardial infarction (AMI). 1 -5 Excessive microvascular destruction is associated with greater infarct size, worse myocardial function, and poor clinical outcome after ST elevation acute myocardial infarction (STEMI). 6 -8 Therefore, assessment of microvascular integrity is an essential part for risk stratification and tailoring the treatment strategies in patients undergoing primary percutaneous intervention for AMI. Doppler 9 -11 or pressure wire 12, 13 derived indices have gained acceptance as a tool to detect microvascular dysfunction after AMI. Moreover, these indices can also successfully predict the recovery of LV function 14 and long-term clinical outcomes. 15 Besides earlier mentioned invasive methods, coronary flow velocity patterns can be easily and reliably measured with transthoracic echocardiography to evaluate microvascular perfusion. 16 Diastolic coronary flow with a rapid deceleration time measured by transthoracic echocardiography or intracoronary Doppler wire in reperfused infarct-related artery implies advanced microvascular damage and predicts LV remodelling and viability. 17 -19 Nevertheless, the comparative value of earlier mentioned different microvascular reperfusion parameters to predict late-term infarct size, LV volumes, and function, particularly in patients undergoing primary angioplasty, has not been fully interrogated. In spite of the proven value of these microvascular perfusion parameters in the prediction of patients' prognosis, application of invasive methods is not practical. Therefore, there is a necessity for a reliable, satisfactory, and easily applicable method for the assessment of microvascular structural and functional integrity. In this study, microvascular perfusion in the territory of percutaneously reperfused infarct-related artery was evaluated measuring the deceleration time of the diastolic coronary flow (DDT) by transthoracic echocardiography and by intracoronary haemodynamic measurements, using pressure-monitoring guide wire; and their predictive values for estimating long-term (6 months) infarct size, LV volumes, and function were compared.
Methods

Patient population
Thirty-four patients with their first anterior ST elevation AMI treated successfully with primary percutaneous coronary intervention (PCI) were prospectively included in this study. Inclusion criteria were continuous chest pain that lasted .30 min within the preceding 12 h and ST-segment elevation of at least 1 mm in two contiguous leads on the surface ECG. Written informed consent was obtained from all of the patients and our local institutional review board approved the study protocol. The study was carried out according to the Declaration of Helsinki.
Intracoronary haemodynamic measurements and angiographic analysis
Patients were recatheterized on the second day (49 + 9 h after primary PCI) for the evaluation of microvascular function with the assumption that at that time dynamic changes in resting microvascular perfusion have subsided. Pressure-temperature sensor-tipped guide wire (Radi Medical Systems, Pressure Wire Sensor 5) was advanced through the guiding catheter and positioned distal to the stented segment of the left anterior descending artery (LAD). Proximal aortic and distal coronary pressures were recorded simultaneously. Intracoronary papaverine was used as the hyperaemic agent. The mean transit times at rest and during hyperaemia were recorded after rapid injection of 4 mL of room-temperature saline through the guiding catheter as described previously. 20 The hyperaemic (Tmn h ) and resting mean transit times (Tmn r ) were measured at least three times and were accepted when the variability between the three values obtained for Tmn r and Tmn h from the three measurements were ,20%. Thermodilution-derived coronary flow reserve (CFR) was calculated as the resting mean transit time divided by the hyperaemic mean transit time. 21 Index of microvascular resistance (IMR) was defined as simultaneously measured distal coronary pressure multiplied by the hyperaemic mean transit time [mmHg seconds, or units (U)]. 22 Subsequently, a short compliant balloon was placed in the stented segment and inflated to measure the coronary wedge pressure (CWP). During total occlusion of the coronary artery, distal pressure obtained from the pressure wire was recorded as CWP. Pressure-derived collateral flow index (CFIp) was calculated by the ratio of simultaneously measured CWP to mean aortic pressure (CFIp ¼ mean CWP/mean aortic pressure).
Analysis of coronary flow velocity pattern
Coronary flow velocity pattern was assessed in LAD using transthoracic echocardiography just before intracoronary haemodynamic measurements at 2 days with Vivid 7 digital ultrasound system (General Electrics) on Day 2. 23 From the coronary flow velocity spectrum, DDT (ms) was measured from the peak diastolic velocity to the point when the extrapolated line intersected the base line for three different cardiac cycles, and the values averaged 24 ( Figure 1 ). Echocardiographic LV ejection fraction by area-length method, end-diastolic (LVEDV), and end-systolic volumes (LVESV) were also measured during this evaluation.
Infarct size calculation
Technetium-99m sestamibi SPECT was utilized to measure infarct size, which was expressed as a percentage of total myocardium. All patients received an intravenous injection of 740 MBq of technetium-99m sestamibi; SPECT acquisitions were performed with a double-head camera system (Vertex plus ADAC/Philips, Eindhoven, The Netherlands) equipped with low-energy, parallel hole collimators 30 min after tracer application. Images were acquired in a 64 × 64 data matrix with an acquisition time of 40 s per projection. The image data were reconstructed over 1808 from 458 right anterior oblique to 458 left posterior oblique by use of a Butterworth filter with a cut-off frequency of 0.45, order 5. SPECT images were analysed by Bull's eye quantitative program to evaluate the infarct size. The size of defect was calculated with the use of a threshold of 60% as derived from phantom studies and was quantified as percentage of LV.
Long-term follow-up
Echocardiography, control angiography, and infarct size measurements were performed 6 months (mean 6.5 + 2.4 months) after primary PCI. Echocardiographic LV ejection fraction (LVEF), LVEDV, LVESV, and scintigraphic infarct size were measured. Patients with .70% stenosis in stented segment at control angiogram were excluded from the lateterm LV volume analysis to avoid the confounding effect of IRA restenosis on LV volumes.
Statistical analysis
Data are expressed as percentage for discrete variables and as mean + SD for continuous variables. First, correlations among microvascular perfusion parameters and LV volumes, function, and long-term infarct size were analysed using linear regression analysis. Second, receiver operating characteristic (ROC) curves were constructed to evaluate the accuracy of indices of microvascular perfusion (IMR, CFR, CWP, CFIp, DDT) in the prediction of 6-month median LVEF (40%) and median infarct size (19%). The suitable cut-off points for each index where sensitivity is nearly equal to specificity as possible were determined. Area under the ROC curves was determined as a scalar measure of performance for each index. Areas under the curves for microvascular perfusion indices in predicting long-term LV infarct size and function were compared with the ROC curve analyser of MedCalc 9.2 (MedCalc, Mariakerke, Belgium).
Results
Study patients, baseline, and angiographic characteristics
Initially, 34 patients with anterior ST elevation AMI were included. Baseline clinical and angiographic characteristics are shown in Table 1 . All of the patients had totally occluded LAD at the initial angiography and were treated with primary angioplasty followed by stent implantation without residual stenosis. All patients received glycoprotein IIb/IIIa inhibitors and clopidogrel. Most of the patients had single-vessel disease (80%), and mean time from symptom onset to first balloon inflation was 237.5 + 160 min. Intracoronary haemodynamic measurements have been successfully carried out in all patients. The variability of mean transit times (Tmn) within each set of three consecutive measurements was 10.5 + 8.1% at rest and 8.8 + 6.5% at hyperaemia. These values are in accordance with earlier studies on coronary thermodilution and reflect that reliable thermodilution curves could have been obtained.
At the long-term follow-up, one patient had coronary artery by-pass graft operation and three patients had significant in-stent restenosis (70%) at the control coronary angiography. Therefore, the remaining 30 patients constituted the final population for long-term LV volume and performance analysis and infarct size measurement.
Relationships between microvascular perfusion parameters and early-phase (pre-discharge) left ventricular volumes and function Table 2) .
Relationship between microvascular perfusion parameters and long-term left ventricular volumes, functions, and infarct size
Thirty patients were included in long-term analysis. Table 2) . Table 2) . Table 2) .
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Left ventricular diastolic volume
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Comparative values of parameters of microvascular perfusion to predict left ventricular function at long term
Respectively ordered area under the curve, sensitivity, and specificity of the microvascular perfusion indices in the prediction of long-term LV ejection fraction were as follows: IMR (0.74 + 0.10, 74%, 82%), CFR (0.70 + 0.11, 69%, 78%), CWP (0.78 + 0.043, 78%, 82%), CFIp (0.74 + 0.037, 75%, 80%), and DDT (0.75 + 0.13, 76%, 72%). There were no significant differences between areas under the curve of microvascular perfusion indices in the prediction of long-term LV ejection fraction ( Table 3) . 
Infarct size
Comparative values of microvascular perfusion parameters to predict long-term infarct size
Area under the curve, sensitivity, and specificity (ordered respectively) of the indices of microvascular perfusion in the prediction of late-term infarct size were as follows: IMR (0.68 + 0.15, 69%, 60%), CFR (0.67 + 0.10, 66%, 59%), CWP (0.69 + 0.12, 70%, 72%), CFIp (0.64 + 0.10, 65%, 78%), and DDT (0.68 + 0.16, 69%, 79%). There were no significant differences between areas under the curve of microvascular perfusion indices in the prediction of long-term infarct size ( Table 4) .
Discussion
The results of the present study demonstrate that predictive accuracy of DDT measured with transthoracic echocardiography on Day 2 for the estimation of long-term infarct size and LV ejection fraction was comparable with invasive indices of microvascular perfusion. Our results also confirmed and expanded the previous observations that the extent of microvascular dysfunction after primary PCI is an important predictor not only for long-term LV function but also for long-term infarct size. Microvascular patency is a requirement for myocardial viability after AMI, and the extent of microvascular impairment is closely related with infarct size and worse outcome. 5 Nevertheless, significant reduction in infarct size long time after AMI can occur during the course of infarct-healing process following reperfusion therapy. 25, 26 Thus, prediction of late-phase (final) infarct size could be more valuable after reperfused AMI as it was done in the present study. It has been shown that spontaneous delayed recovery of the perfusion after AMI leads to significant decrease in infarct size (by 31%) at long-term, suggesting the presence of stunning and hibernating myocardium. 25, 26 Therefore, different from previous studies investigating microvascular function and early-phase infarct size, one of the our main comparator was the long-term infarct size in the present study.
In the current study, we assessed microvascular functions on Day 2 after reperfused AMI. Resting myocardial perfusion changed dynamically within 48 h of the AMI mainly due to the ongoing nature of the microvascular damage and subsided after this period. 5, 27 Therefore, the assessment of microvascular function could be more reliable and physiological with performing the measurements at that time and relate the findings with longterm infarct size and LV volumes and function. Concordantly, all microvascular perfusion indices, which were determined on Day 2 after reperfusion, had good correlations with late-term infarct size and LV volumes and function. The present study has also provided new information as to whether the accuracy of echocardiographically measured DDT is comparable with that of invasive indices of microvascular integrity for predicting long-term LV infarct size and function. Our results showed that areas under the curve were similar among all microvascular integrity indexes that were used to estimate long-term LV infarct size and function. These findings indicated that DDT measured by transthoracic echocardiography on Day 2 after reperfused AMI is as accurate as invasive microvascular indices measured by intracoronary pressure wire for predicting long-term infarct size and LV function.
A rapid deceleration in diastolic coronary flow velocity is a typical finding of the microvascular damage and can indicate the no-reflow after AMI better than other modalities. 28 In previous studies, DDT was proved to be a sensitive parameter for estimating the amount of microvascular dysfunction, LV dilation, 18, 29, 30 complications, and in-hospital survival after AMI. 17 Although 600 ms of DDT is accepted as a cut-off value to predict microvascular dysfunction, 31 there is no established data for the best cut-off value in predicting long-term infarct size and LV function. We present the first result of best cut-off values of the DDT as 595 ms for the estimation of long-term infarct size and 580 ms for LV function. Furthermore, the accuracy of DDT in predicting long-term LV infarct size and function were comparable with other invasive indices of microvascular integrity. Cut-off values reported in the previous studies for CWP/mean aortic pressure 12 and IMR 22 in predicting microvascular dysfunction and CFR for predicting microvascular dysfunction 10 and LV remodelling 32 were consistent with the results of the current study. Deceleration time of the coronary diastolic flow can be easily and reliably measured by transthoracic Doppler echocardiography without administering any additional hyperaemic stimuli. Additionally, it has been demonstrated in this study that DDT is as accurate as other invasive markers of microvascular function in estimating long-term infarct size and LV function. Optimal timing to predict LV remodelling based on the microvascular assessment has been considered as 2 -7 days after AMI. 27 Therefore, measuring of DDT in reperfused infarct-related artery 2 days after AMI can provide useful and reliable estimates for early risk stratification and make planning of long-term management in patients who were treated with primary PCI easier and more reliable. Although availability and applicability of the invasive indices are usually limited with small numbers of investigational cases, it is easy to measure DDT in most of the patients especially in left anterior descending artery. Besides its comparable predictive power in estimating long-term LV infarct size and function, convenience of the application makes this method useful and unique in terms of clinical requirements. 
Study limitations
The results of the present study should be considered in the light of some limitations. First, although coronary microcirculation was carefully interrogated using multiple sensitive indexes at specific time points, the study population was relatively small. Second, central venous pressure was not measured for the calculation of pressure-derived CFIp based on an assumption that all patients had low and negligible central venous pressure. At last, we studied only patients with acute anterior MI who underwent successful primary PCI, because it was difficult to determine DDT of coronary flow by transthoracic echocardiography in circumflex and right coronary artery. Therefore, our results may not be generally applied to all patients receiving reperfusion therapy.
